Daiichi Sankyo Company, Limited DSKYF OTC

Daiichi Sankyo Company, Limited (DSKYF) reported total assets of $3.46T and total liabilities of $1.83T for fiscal year 2025, resulting in total equity of $1.62T.

The company held $720.73B in cash and short-term investments. Total debt stood at $101.33B, with net debt of $-538.51B. The Debt-to-Equity (D/E) ratio was 0.06 (conservative).

Current ratio is 2.53, indicating strong short-term liquidity. Interest coverage is 28x (strong).

Criteria supported by this page:

• HEALTH (100/100, Pass) — Debt-to-Equity of 0.06, current ratio of 2.53, interest coverage 28x — balance sheet is strong
• MOAT (88/100) — Total assets $3.46T and equity $1.62T support the company's competitive scale
• VALUE (100/100) — Debt-to-Equity 0.06 contributes to the overall valuation risk assessment

Overall SharesGrow Score: 90/100 with 6/7 criteria passed.

RHHBY

Roche Holding AG

$51.02

+0.65%

AZN

AstraZeneca PLC

$204.38

+1.06%

NVS

Novartis AG

$153.38

-0.71%

AZNCF

AstraZeneca PLC

$189.90

-1.35%

AMGN

Amgen Inc.

$350.95

+0.32%

GSK

GSK plc

$59.18

+0.41%

BMY

Bristol-Myers Squibb Company

$58.08

+0.03%

SNY

Sanofi

$47.64

+1.45%